Australia approves pTau217 blood test with 18-minute turnaround

Australia's TGA has approved Roche's pTau217 blood test for Alzheimer's detection, with 90% accuracy and rapid turnaround. A new Asia-Pacific Centre of Excellence has been established, and the ASAP Act aims to transform early detection, modeled on breast cancer screening. Personal story of Nell Hawe illustrates potential 20-year lead time. This is a major regulatory milestone for blood-based biomarkers.